Sally Lawlor

Sally Lawlor joined Quoin Pharmaceuticals in August 2025 as Chief Financial Officer. She brings 20 years of finance experience across Big Four accounting and senior roles in public and private companies. Most recently, she held senior finance positions at Sebela Pharmaceuticals, overseeing audited financials under U.S. GAAP and IFRS, FP&A, budgeting, cash management, and global tax compliance. Previously, she served at Aptiv Plc as EMA Tax Lead and Director of Global Tax Planning. Earlier, Lawlor spent over a decade with KPMG advising multinational clients in the pharmaceutical and technology sectors. She is a Fellow of Chartered Accountants Ireland, a member of the Irish Taxation Institute, and holds a bachelor’s degree in Law and German from University College Cork.